,trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['breast', 'destiny-breast04']
destiny-breast04 is a game changer with a novel concept of effective her2 targeting in her2 low breast cancer. i am looking forward to the presentation later today at #asco22 
Medical Oncologist, Cancer Researcher, Drug Developer, ex-@MDAndersonNews, Chief Medical Officer @MonteRosaTx. Views are mine.